Cargando…
Expensive medicines: ensuring objective appraisal and equitable access
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271687/ https://www.ncbi.nlm.nih.gov/pubmed/25558099 http://dx.doi.org/10.2471/BLT.14.148924 |
_version_ | 1782349653887418368 |
---|---|
author | Hill, Suzanne R Bero, Lisa McColl, Geoff Roughead, Elizabeth |
author_facet | Hill, Suzanne R Bero, Lisa McColl, Geoff Roughead, Elizabeth |
author_sort | Hill, Suzanne R |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4271687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | World Health Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-42716872015-01-02 Expensive medicines: ensuring objective appraisal and equitable access Hill, Suzanne R Bero, Lisa McColl, Geoff Roughead, Elizabeth Bull World Health Organ Editorials World Health Organization 2015-01-01 /pmc/articles/PMC4271687/ /pubmed/25558099 http://dx.doi.org/10.2471/BLT.14.148924 Text en (c) 2015 The authors; licensee World Health Organization. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. |
spellingShingle | Editorials Hill, Suzanne R Bero, Lisa McColl, Geoff Roughead, Elizabeth Expensive medicines: ensuring objective appraisal and equitable access |
title | Expensive medicines: ensuring objective appraisal and equitable access |
title_full | Expensive medicines: ensuring objective appraisal and equitable access |
title_fullStr | Expensive medicines: ensuring objective appraisal and equitable access |
title_full_unstemmed | Expensive medicines: ensuring objective appraisal and equitable access |
title_short | Expensive medicines: ensuring objective appraisal and equitable access |
title_sort | expensive medicines: ensuring objective appraisal and equitable access |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271687/ https://www.ncbi.nlm.nih.gov/pubmed/25558099 http://dx.doi.org/10.2471/BLT.14.148924 |
work_keys_str_mv | AT hillsuzanner expensivemedicinesensuringobjectiveappraisalandequitableaccess AT berolisa expensivemedicinesensuringobjectiveappraisalandequitableaccess AT mccollgeoff expensivemedicinesensuringobjectiveappraisalandequitableaccess AT rougheadelizabeth expensivemedicinesensuringobjectiveappraisalandequitableaccess |